BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7795238)

  • 21. Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas.
    Gombart AF; Morosetti R; Miller CW; Said JW; Koeffler HP
    Blood; 1995 Aug; 86(4):1534-9. PubMed ID: 7632961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.
    Linardopoulos S; Street AJ; Quelle DE; Parry D; Peters G; Sherr CJ; Balmain A
    Cancer Res; 1995 Nov; 55(22):5168-72. PubMed ID: 7585567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG; Jen J; Merlo A; Baylin SB
    Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood.
    Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y
    Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations.
    Maloney KW; McGavran L; Odom LF; Hunger SP
    Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
    Delmer A; Tang R; Senamaud-Beaufort C; Paterlini P; Brechot C; Zittoun R
    Leukemia; 1995 Jul; 9(7):1240-5. PubMed ID: 7630199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
    Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS
    Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of T-cell acute lymphoblastic leukemia proliferation in vivo by re-expression of the p16INK4a tumor suppressor gene.
    Schoppmeyer K; Norris PS; Haas M
    Neoplasia; 1999 Jun; 1(2):128-37. PubMed ID: 10933047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia.
    Hatta Y; Hirama T; Miller CW; Yamada Y; Tomonaga M; Koeffler HP
    Blood; 1995 May; 85(10):2699-704. PubMed ID: 7742529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
    Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K
    Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan.
    Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC
    Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection.
    Kim JW; Namkoong SE; Ryu SW; Kim HS; Shin JW; Lee JM; Kim DH; Kim IK
    Gynecol Oncol; 1998 Jul; 70(1):75-9. PubMed ID: 9698478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of the p15, p16,and p18 genes in osteosarcoma.
    Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
    Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders.
    Kawamata N; Inagaki N; Mizumura S; Sugimoto KJ; Sakajiri S; Ohyanagi-Hara M; Oshimi K
    Eur J Haematol; 2005 May; 74(5):424-9. PubMed ID: 15813917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p16 gene homozygous deletions in acute lymphoblastic leukemia.
    Quesnel B; Preudhomme C; Philippe N; Vanrumbeke M; Dervite I; Lai JL; Bauters F; Wattel E; Fenaux P
    Blood; 1995 Feb; 85(3):657-63. PubMed ID: 7833469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors.
    Knapek DF; Serrano M; Beach D; Trono D; Walker CL
    Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
    Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
    Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of cyclin dependent kinase inhibitors, p16INK4a and p15INK4b gene, in acute lymphoblastic leukemias].
    Kaname M; Watanabe H; Fukuchi K; Akagi Y; Takagi Y; Tomoyasu S; Tsuruoka N; Gomi K
    Rinsho Byori; 1996 Aug; 44(8):771-7. PubMed ID: 8816064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p16INK4/p15INK4B gene inactivation is a frequent event in malignant T-cell lines.
    Borgonovo Brandter L; Heyman M; Rasool O; Liu Y; Grandér D; Einhorn S
    Eur J Haematol; 1996 May; 56(5):313-8. PubMed ID: 8641406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.